Cecilia Monge Bonilla (Cecilia Monge)

Publication Activity (10 Years)

Years Active: 2018-2024
Publications (10 Years): 26

Top Topics

Radiofrequency Ablation

Metastatic Colorectal Cancer

Top Venues

Journal for immunotherapy of cancer

Cancer medicine

Journal of hepatocellular carcinoma

Journal of racial and ethnic health disparities

This page only lists publications with an associated author ORCID identifier.

Publications

Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Kelley L Coffman-D'Annibale, Yuta Myojin, Cecilia Monge Bonilla, Changqing Xie, Donna Mabry Hrones, Bradford J Wood, Elliot B Levy, David Kleiner, William Douglas Figg, Seth M Steinberg, Bernadette Redd, Tim F Greten
VB-111 (ofranergene obadenovec) in combination with nivolumab in patients with microsatellite stable colorectal liver metastases: a single center, single arm, phase II trial. Journal for immunotherapy of cancer 12 (1) (2024)
Gabriela Arroyo Figueroa, Tim F Greten, Cecilia Monge Bonilla
Unveiling Disparities: Analyzing Hispanic Inclusion in Liver Cancer Research Databases in the United States. Journal of racial and ethnic health disparities (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine (2024)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley L Coffman-D'Annibale, Donna Hrones, Gagandeep Brar, Sophie Wang, Anuradha Budhu, William D Figg, Maggie Cam, Richard Finney, Elliot B Levy, David E Kleiner, Seth M Steinberg, Xin Wei Wang, Bernadette Redd, Bradford J Wood, Tim F Greten
Combined immune checkpoint inhibition with durvalumab and tremelimumab with and without radiofrequency ablation in patients with advanced biliary tract carcinoma. Cancer medicine 13 (3) (2024)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine 13 (1) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, J Alberto Maldonado, Katherine A McGlynn, Tim F Greten
Hispanic Individuals are Underrepresented in Phase III Clinical Trials for Advanced Liver Cancer in the United States. Journal of hepatocellular carcinoma 10 (2023)
Cecilia Monge Bonilla, Changqing Xie, Yuta Myojin, Kelley Coffman, Donna Mabry Hrones, Sophie Wang, Jonathan M Hernandez, Bradford J Wood, Elliot B Levy, Israa Juburi, Stephen M Hewitt, David E Kleiner, Seth M Steinberg, William D Figg, Bernadette Redd, Philip Homan, Maggie Cam, Benjamin Ruf, Austin G Duffy, Tim F Greten
Phase I/II study of PexaVec in combination with immune checkpoint inhibition in refractory metastatic colorectal cancer. Journal for immunotherapy of cancer 11 (2) (2023)
Cecilia Monge Bonilla, Tim F Greten
Underrepresentation of Hispanics in clinical trials for liver cancer in the United States over the past 20 years. Cancer medicine (2023)
Kelley Coffman-D'Annibale, Changqing Xie, Donna M Hrones, Shadin Ghabra, Tim F Greten, Cecilia Monge Bonilla
The Current Landscape of Therapies for Hepatocellular Carcinoma. Carcinogenesis (2023)
Cecilia Monge Bonilla, Erica C Pehrsson, Changqing Xie, Austin G Duffy, Donna Mabry, Bradford J Wood, David E Kleiner, Seth M Steinberg, William Douglas Figg, Bernadette Redd, Anuradha Budhu, Sophie Wang, Mayank Tandon, Lichun Ma, Xin Wei Wang, Tim F Greten
A Phase II Study of Pembrolizumab in Combination with Capecitabine and Oxaliplatin with Molecular Profiling in Patients with Advanced Biliary Tract Carcinoma. The oncologist 27 (3) (2022)
Cecilia Monge Bonilla, Changqing Xie, Seth M Steinberg, Tim F Greten
Clinical Indicators for Long-Term Survival with Immune Checkpoint Therapy in Advanced Hepatocellular Carcinoma. Journal of hepatocellular carcinoma 8 (2021)
Cecilia Monge Bonilla, Hoyoung Maeng, Alessandra Brofferio, Andrea B Apolo, Bharath Sathya, Andrew E Arai, James L Gulley, Marijo Bilusic
Myocarditis in a patient treated with Nivolumab and PROSTVAC: a case report. Journal for immunotherapy of cancer 6 (1) (2018)